Combination chemotherapy for advanced hepatocellular carcinoma complicated by major portal vein thrombosis

被引:37
作者
Kaneko, S [1 ]
Urabe, T [1 ]
Kobayashi, K [1 ]
机构
[1] Kanazawa Univ Hosp, Kanazawa Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan
关键词
chemotherapy; hepatocellular carcinoma; interferon; 5-fluorouracil; cisplatin; portal vein thrombosis;
D O I
10.1159/000048279
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Patients with advanced hepatocellular carcinoma (HCC) have a poor prognosis, and the development of new therapeutic strategies is necessary. Here we report the efficacy of combination chemotherapy in our biochemical modulation. Synergistic effects of interferon-alpha-2b on 5-fluorouracil or cisplatin were demonstrated in Huh7 cells. The efficacy of methotrexate-5-fluorouracil, cisplatin, and interferon-a-2b combination therapy was demonstrated in 34 patients with HCC complicated by major portal vein thrombosis. Among the 29 patients eligible for the study, there were 3 complete responders and 10 partial responders with an overall response rate of 45%. The 2-year survival of the 34 patients was 15%, and the median survival of complete and partial responders was 11 months. There was severe transient hematological toxicity. Eight patients suffered from renal insufficiency, and 4 of them underwent hemodialysis. Although a control study is clearly necessary, our combination therapy induced a good response in the patients with advanced HCC. On the basis of our results, intensive chemotherapy should be attempted in advanced HCC complicated by major portal vein invasion. Copyright (C) 2002 S. Karger AG, Basel.
引用
收藏
页码:69 / 73
页数:5
相关论文
共 40 条
  • [1] CONCOMITANT ALPHA-INTERFERON AND CHEMOTHERAPY IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
    BENASSO, M
    MERLANO, M
    BLENGIO, F
    CAVALLARI, M
    ROSSO, R
    TOMA, S
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1993, 16 (06): : 465 - 468
  • [2] CARR BI, 1991, HEPATOLOGY, V14, pA108
  • [3] DOCI R, 1988, CANCER, V61, P1983, DOI 10.1002/1097-0142(19880515)61:10<1983::AID-CNCR2820611009>3.0.CO
  • [4] 2-V
  • [5] FALKSON G, 1984, CANCER, V54, P970, DOI 10.1002/1097-0142(19840915)54:6<970::AID-CNCR2820540604>3.0.CO
  • [6] 2-7
  • [7] *GASTR TUM STUD GR, 1990, CANCER, V66, P135
  • [8] GLIMELIUS B, 1989, J CLIN ONCOL, V7, P1437
  • [9] HOUGHTON JA, 1993, CANCER RES, V53, P4243
  • [10] ILSON DH, 1995, CANCER, V75, P2197, DOI 10.1002/1097-0142(19950501)75:9<2197::AID-CNCR2820750902>3.0.CO